Aduro Biotech (ADRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADRO | IRD | NVCT | ||
| Company | Aduro Biotech | Opus Genetics Inc | Nuvectis Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.05 | 3.51 | 8.99 | ||
| High | 14.86 | 3.60 | 8.99 | ||
| Low | 13.92 | 3.43 | 8.70 | ||
| Latest | 14.60 | 3.59 | 8.94 | ||
| Change | +0.59 | +0.09 | +0.01 | ||
| % Change | +4.18% | +2.57% | +0.11% | ||
| Volume | 171,500 | 460,800 | 33,000 | ||
| 20-Day Average Volume | 149,894 | 1,130,805 | 61,815 | ||
| Previous Close | 14.01 | 3.50 | 8.93 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 12.53 | 3.17 | 8.65 | ||
| 20-Day Raw Stochastic | 76.03% | 78.63% | 77.52% | ||
| 20-Day Relative Strength | 56.92 | 62.79 | 58.02 | ||
| Weighted Alpha | +96.00 | +234.42 | +34.14 | ||
| Today's Opinion | 40% Buy | 100% Buy | 80% Buy | ||
| Previous Opinion | 32% Buy | 100% Buy | 80% Buy | ||
| Last Month's Opinion | 56% Buy | 100% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +23.16% since 09/28/20 | +0.56% since 02/19/26 | +5.05% since 02/19/26 | ||
| Low | 11.30 on 10/02/20 | 3.29 on 02/23/26 | 8.20 on 02/25/26 | ||
| High | 15.73 on 10/02/20 | 3.75 on 02/24/26 | 9.12 on 02/25/26 | ||
| 1-Month | |||||
| %Chg | +9.74% since 09/04/20 | +27.76% since 01/26/26 | +5.05% since 01/26/26 | ||
| Low | 11.00 on 09/24/20 | 2.21 on 02/05/26 | 7.94 on 01/30/26 | ||
| High | 15.73 on 10/02/20 | 3.96 on 02/17/26 | 9.23 on 02/13/26 | ||
| 3-Month | |||||
| %Chg | +16.76% since 07/02/20 | +77.72% since 11/26/25 | +47.52% since 11/26/25 | ||
| Low | 11.00 on 09/24/20 | 1.88 on 01/12/26 | 5.77 on 12/02/25 | ||
| High | 17.20 on 08/18/20 | 3.96 on 02/17/26 | 9.44 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +14.92% since 04/03/20 | +197.93% since 08/26/25 | +30.51% since 08/26/25 | ||
| Low | 10.50 on 06/26/20 | 1.17 on 08/29/25 | 5.55 on 11/07/25 | ||
| High | 17.70 on 05/28/20 | 3.96 on 02/17/26 | 9.44 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 236,614 | 241,374 | 236,574 | ||
| Shares Outstanding, K | 16,212 | 68,964 | 26,492 | ||
| Annual Sales | 17,260,000 | 10,990,000 | 0 | ||
| Annual Net Income | -82,370,000 | -57,530,000 | -26,440,000 | ||
| Last Quarter Sales | 5,570,000 | 3,080,000 | 0 | ||
| Last Quarter Net Income | -16,620,000 | -17,450,000 | -7,310,000 | ||
| 60-Month Beta | 0.40 | 0.58 | -0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.12 on 11/12/25 | -0.44 on 11/04/25 | ||
| Latest Earnings Date | 11/05/20 | 03/30/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||